Aeglea BioTherapeutics Holdings
Austin, US · Founded 2013
Founders & leadership
Aeglea BioTherapeutics Holdings was founded in 2013 by David Lowe and George Georgiou.
DL
David LoweCo-founder
GG
George GeorgiouCo-founder
CY
Charles YorkExecutive
Board
AS
Armen ShanafeltBoard director
HS
Henry SkinnerBoard director
Reported raises · per SEC filings
Form D private placements$10.7M disclosed across 1 round · 2013
▶$10.7MraisedJul 2014 · 10 investors · BiotechnologyRule 506(b)
▶$10.7MraisedJul 2014 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Armen ShanafeltDirector
- David LoweExecutive Officer, Director
- Charles YorkExecutive Officer
- Henry SkinnerDirector
- George GeorgiouDirector
- Offering amount
- $11M
- Amount sold
- $10.7M
- First sale
- Dec 2013
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Aeglea BioTherapeutics Holdings?
- Aeglea BioTherapeutics Holdings was founded by David Lowe, George Georgiou in 2013.
- How much funding has Aeglea BioTherapeutics Holdings raised?
- Aeglea BioTherapeutics Holdings has disclosed $10.7M raised across 1 round.
- Where is Aeglea BioTherapeutics Holdings headquartered?
- Aeglea BioTherapeutics Holdings is headquartered in Austin, US.